These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17245003)

  • 1. Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancers.
    Nishimura R; Saeki T; Ohsumi S; Tani Y; Takashima S
    Breast Cancer; 2007; 14(1):100-4. PubMed ID: 17245003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratio.
    Van den Eynden GG; Colpaert CG; Vermeulen PB; Weyler JJ; Goovaerts G; van Dam P; Van Marck EA; Dirix LY
    Pathol Res Pract; 2002; 198(8):517-24. PubMed ID: 12389994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
    Zafrani B; Aubriot MH; Mouret E; De Crémoux P; De Rycke Y; Nicolas A; Boudou E; Vincent-Salomon A; Magdelénat H; Sastre-Garau X
    Histopathology; 2000 Dec; 37(6):536-45. PubMed ID: 11122436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients.
    Kurosumi M
    Breast Cancer; 2003; 10(2):97-104. PubMed ID: 12736561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients.
    Ferrero-Poüs M; Trassard M; Le Doussal V; Hacène K; Tubiana-Hulin M; Spyratos F
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):267-75. PubMed ID: 11556756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma.
    Golouh R; Vrhovec I; Bracko M; Frković-Grazio S
    Pathol Res Pract; 1997; 193(8):543-9. PubMed ID: 9406247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
    J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods.
    Mink D; Hollaender M; von Tongelen B; Villena-Heinsen C; Schmidt W
    Eur J Gynaecol Oncol; 1995; 16(2):81-91. PubMed ID: 7641743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
    Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D
    J BUON; 2013; 18(3):619-22. PubMed ID: 24065473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
    Khabaz MN
    Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA
    Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
    De La Cruz LM; Harhay MO; Zhang P; Ugras S
    Ann Surg Oncol; 2018 Nov; 25(12):3535-3540. PubMed ID: 29981025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
    Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
    Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
    Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.